Literature DB >> 27706808

Understanding the regulation of pattern recognition receptors in inflammatory diseases - a 'Nod' in the right direction.

Claire L Feerick1, Declan P McKernan1.   

Abstract

Nucleotide-binding oligomerization domain (NOD) -like receptors (NLRs) are a family of 23 receptors known as pattern recognition receptors; they are expressed in many cell types and play a key role in the innate immune response. The NLRs are activated by pathogen-associated molecular patterns, which include structurally conserved molecules present on the surfaces of bacteria. The activation of these NLRs by pathogens results in the downstream activation of signalling kinases and transcription factors, culminating in the transcription of genes coding for pro-inflammatory factors. Expression of NLR is altered in many cellular, physiological and disease states. There is a lack of understanding of the mechanisms by which NLR expression is regulated, particularly in chronic inflammatory states. Genetic polymorphisms and protein interactions are included in such mechanisms. This review seeks to examine the current knowledge regarding the regulation of this family of receptors and their signalling pathways as well as how their expression changes in disease states with particular focus on NOD1 and NOD2 in inflammatory bowel diseases among others.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  NLR expression; NOD1; NOD2; inflammation; inflammatory bowel disease

Mesh:

Substances:

Year:  2016        PMID: 27706808      PMCID: PMC5290251          DOI: 10.1111/imm.12677

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  109 in total

1.  Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease.

Authors:  Wenjing Jia; Rebekah N Whitehead; Lesley Griffiths; Claire Dawson; Hao Bai; Rosemary H Waring; David B Ramsden; John O Hunter; Michael Cauchi; Conrad Bessant; Dawn P Fowler; Christopher Walton; Claire Turner; Jeffrey A Cole
Journal:  FEMS Immunol Med Microbiol       Date:  2012-02-28

2.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

Authors:  Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

3.  PSMA7 directly interacts with NOD1 and regulates its function.

Authors:  Liuzhong Yang; Zheng Tang; Huiqiang Zhang; Weizheng Kou; Zhihong Lu; Xiaorui Li; Qiuping Li; Zhanhui Miao
Journal:  Cell Physiol Biochem       Date:  2013-06-26

4.  Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.

Authors:  Yi-Jun Zhou; Cong Liu; Chun-Li Li; Yu-Ling Song; Yin-Si Tang; Hui Zhou; Ai Li; Yan Li; Yang Weng; Fang-Ping Zheng
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

5.  Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.

Authors:  Jean-Pierre Hugot; Isabelle Zaccaria; Juleen Cavanaugh; Huiying Yang; Séverine Vermeire; Maarit Lappalainen; Stefan Schreiber; Vito Annese; Derek P Jewell; Elizabeth V Fowler; Steven R Brant; Mark S Silverberg; Judy Cho; John D Rioux; Jack Satsangi; Miles Parkes
Journal:  Am J Gastroenterol       Date:  2007-02-23       Impact factor: 10.864

6.  A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.

Authors:  Mizuho Hasegawa; Yukari Fujimoto; Peter C Lucas; Hiroyasu Nakano; Koichi Fukase; Gabriel Núñez; Naohiro Inohara
Journal:  EMBO J       Date:  2007-12-13       Impact factor: 11.598

7.  Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.

Authors:  L A Simms; J D Doecke; M D Walsh; N Huang; E V Fowler; G L Radford-Smith
Journal:  Gut       Date:  2008-02-27       Impact factor: 23.059

8.  NOD1 expression is increased in the adipose tissue of women with gestational diabetes.

Authors:  Martha Lappas
Journal:  J Endocrinol       Date:  2014-05-14       Impact factor: 4.286

9.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

10.  TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation.

Authors:  Birte Zurek; Ida Schoultz; Andreas Neerincx; Luisa M Napolitano; Katharina Birkner; Eveline Bennek; Gernot Sellge; Maria Lerm; Germana Meroni; Johan D Söderholm; Thomas A Kufer
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

View more
  22 in total

1.  Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.

Authors:  Franco B Mueller; Hua Yang; Michelle Lubetzky; Akanksha Verma; John R Lee; Darshana M Dadhania; Jenny Z Xiang; Steven P Salvatore; Surya V Seshan; Vijay K Sharma; Olivier Elemento; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  JCI Insight       Date:  2019-07-11

Review 2.  Drosophila as a model to explore secondary injury cascades after traumatic brain injury.

Authors:  Lori M Buhlman; Gokul Krishna; T Bucky Jones; Theresa Currier Thomas
Journal:  Biomed Pharmacother       Date:  2021-08-27       Impact factor: 7.419

3.  Comparative Transcriptome Analysis of Head Kidney of Aeromonas hydrophila-infected Hypoxia-tolerant and Normal Large Yellow Croaker.

Authors:  Yibo Zhang; Weiliang Shen; Jie Ding; Xinming Gao; Xiongfei Wu; Junquan Zhu
Journal:  Mar Biotechnol (NY)       Date:  2022-09-21       Impact factor: 3.727

Review 4.  Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

5.  Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome.

Authors:  Christine McDonald; Min Shen; Erin E Johnson; Amrita Kabi; Qingping Yao
Journal:  Autoimmunity       Date:  2018-02-22       Impact factor: 2.815

6.  IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent.

Authors:  Clare S Hardman; Yi-Ling Chen; Maryam Salimi; Janina Nahler; Daniele Corridoni; Marta Jagielowicz; Chathuranga L Fonseka; David Johnson; Emmanouela Repapi; David J Cousins; Jillian L Barlow; Andrew N J McKenzie; Alison Simmons; Graham Ogg
Journal:  Sci Immunol       Date:  2021-05-21

7.  Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways.

Authors:  Cristina Cirauqui; Cristina Benito-Villalvilla; Silvia Sánchez-Ramón; Sofía Sirvent; Carmen M Diez-Rivero; Laura Conejero; Paola Brandi; Lourdes Hernández-Cillero; Juliana Lucía Ochoa; Beatriz Pérez-Villamil; David Sancho; José Luis Subiza; Oscar Palomares
Journal:  Eur J Immunol       Date:  2017-09-14       Impact factor: 5.532

8.  The Stoichiometric Interaction of the Hsp90-Sgt1-Rar1 Complex by CD and SRCD Spectroscopy.

Authors:  Giuliano Siligardi; Minghao Zhang; Chrisostomos Prodromou
Journal:  Front Mol Biosci       Date:  2018-01-17

Review 9.  Development of targeted adjuvants for HIV-1 vaccines.

Authors:  Jun Liu; Mario Ostrowski
Journal:  AIDS Res Ther       Date:  2017-09-12       Impact factor: 2.250

Review 10.  NOD2 and inflammation: current insights.

Authors:  Anna Negroni; Maria Pierdomenico; Salvatore Cucchiara; Laura Stronati
Journal:  J Inflamm Res       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.